Investigation of molecular mechanisms of Sox9 transcriptional factory during enchandral ossification

掌骨骨化过程中Sox9转录工厂的分子机制研究

基本信息

  • 批准号:
    17209059
  • 负责人:
  • 金额:
    $ 29.95万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2007
  • 项目状态:
    已结题

项目摘要

Tb investigate the molecular mechanism by which Sox9 plays an essential role in chondrocyte differentiation, we established a gene screening system for identifying the members of Sox9 transcriptional factory. Using this system, we could identify a calcium ion channel, TRPV_4, as a member of Sox9 transcriptional factory, and found that TRPV4 upregulated expression and function of Sox9, thereby stimulating chondrocyte differentiation. We further screened cDNA library generated from chondrogenic cell line, ATDC5, and isolated the Znf219 cDNA. Whole mount in situ and RT-PCR analyses indicated that Znf219 is specifically expressed in limb bud of E12.5 embryo mice and chondrocytes. Co-immunoprecipitation experiments indicated that Znf219 physically interacts with Sox9. Moreover, we found that Znf219 co-localized with Sox9 in the nucleus. These results indicated that Znf219 forms transcriptional factory in the nucleus. To understand the functional role of Znf219 m chondrocyte differentiation, we next examined the effect of overexpression of Zof219 on chondrocyte differentiation. We found that overexpression of Znf219 stimulated the chondrogenic activity of Sox9. In contrast, overexpression of a dominant negative Znf219 markedly inhibited chondrocyte differentiation induced by Sox9. Furthermore, knockdown of Znf219 using micro RNA system suppressed chondrocyte differentiation. Collectively, our results demonstrated that Znf219 might play an important role in Sox9-regulated chondrocyte differentiation.
为了研究Sox9在软骨细胞分化中发挥重要作用的分子机制,我们建立了一个基因筛选系统来鉴定Sox9转录工厂的成员。利用该系统,我们可以识别钙离子通道TRPV_4作为Sox9转录工厂的成员,并发现TRPV4上调Sox9的表达和功能,从而刺激软骨细胞分化。我们进一步筛选了从软骨形成细胞系 ATDC5 生成的 cDNA 文库,并分离了 Znf219 cDNA。原位整体安装和RT-PCR分析表明Znf219在E12.5胚胎小鼠的肢芽和软骨细胞中特异性表达。免疫共沉淀实验表明 Znf219 与 Sox9 存在物理相互作用。此外,我们发现 Znf219 与 Sox9 在细胞核中共定位。这些结果表明Znf219在细胞核中形成转录工厂。为了了解 Znf219 m 软骨细胞分化的功能作用,我们接下来检查了 Zof219 过表达对软骨细胞分化的影响。我们发现 Znf219 的过度表达刺激了 Sox9 的软骨形成活性。相反,显性失活 Znf219 的过度表达显着抑制 Sox9 诱导的软骨细胞分化。此外,使用 micro RNA 系统敲低 Znf219 可抑制软骨细胞分化。总的来说,我们的结果表明 Znf219 可能在 Sox9 调节的软骨细胞分化中发挥重要作用。

项目成果

期刊论文数量(35)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
CCAAT/enhancer binding protein β isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytes
CCAAT/增强子结合蛋白 β 亚型、富含肝脏的抑制蛋白,调节成骨细胞和脂肪细胞的定向
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hata;K;Nishimura;R;Ueda;M;Ikeda;F;Matsubara;T;lchide;F;Hisada;K;Nokubi;T;Yamaguchi;A;Yoneda;T
  • 通讯作者:
    T
β-Trcp1ユビキチン化システムによるIhh/Gli2誘導性骨芽細胞分化の制御
β-Trcp1 泛素化系统对 Ihh/Gli2 诱导的成骨细胞分化的调节
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    和田 誠大;ら
  • 通讯作者:
Biology of cancer-induced bone diseases
癌症引起的骨疾病的生物学
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yoneda;T
  • 通讯作者:
    T
Preferential inhibition of bone metastases by 5'-deoxy-5-fluorouridine and capecitabine in the 4T1/luc mouse breast cancer model.
在 4T1/luc 小鼠乳腺癌模型中,5-脱氧-5-氟尿苷和卡培他滨优先抑制骨转移。
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hiraga T;Hata K;Ikeda F;Kitagaki J;Fujimoto-Ouchi K;Tanaka Y;Yoneda T.
  • 通讯作者:
    Yoneda T.
Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-β enhances bone metastases in breast cancer
  • DOI:
    10.1158/0008-5472.can-05-2012
  • 发表时间:
    2006-02-15
  • 期刊:
  • 影响因子:
    11.2
  • 作者:
    Hiraga, T;Myoui, A;Yoneda, T
  • 通讯作者:
    Yoneda, T
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YONEDA Toshiyuki其他文献

YONEDA Toshiyuki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YONEDA Toshiyuki', 18)}}的其他基金

Identification of genes involved in biological crosstalk between cancer and bone
鉴定参与癌症和骨骼之间生物串扰的基因
  • 批准号:
    23659870
  • 财政年份:
    2011
  • 资助金额:
    $ 29.95万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Molecular mechanim of cancer-associated bone pain caused by protons
质子引起癌症相关骨痛的分子机制
  • 批准号:
    23390422
  • 财政年份:
    2011
  • 资助金额:
    $ 29.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Integrative Study of transcriptional network systems during enchondral ossification
软骨骨化过程中转录网络系统的综合研究
  • 批准号:
    20229010
  • 财政年份:
    2008
  • 资助金额:
    $ 29.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Cross talk between bone microenvironment and metastatic cancer cell
骨微环境与转移癌细胞之间的串扰
  • 批准号:
    17014058
  • 财政年份:
    2005
  • 资助金额:
    $ 29.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Cloning of the molecules associated with bone metastases of cancers and its characterization
癌症骨转移相关分子的克隆及其表征
  • 批准号:
    11557136
  • 财政年份:
    1999
  • 资助金额:
    $ 29.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The Regulation of Bone-Remodeling by Signals mediated by Phosphorylation
磷酸化介导的信号对骨重建的调节
  • 批准号:
    11307041
  • 财政年份:
    1999
  • 资助金额:
    $ 29.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了